Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
allogeneic bone marrow-derived multipotent mesenchymal stromal cells
- Development stage
- Phase 1
- Lead developer
- University of Texas Health Science Center at Houston
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous
01
Overview
This investigational cell therapy consists of allogeneic bone marrow-derived multipotent mesenchymal stromal cells (MSCs) developed by The University of Texas Health Science Center at Houston (UTHealth Houston). It is currently being evaluated in a Phase 1 clinical trial as an adjunctive treatment for patients with treatment-resistant bipolar depression who exhibit elevated levels of C-reactive protein (CRP), a marker of systemic inflammation. The therapy is hypothesized to exert its antidepressant effects by reducing neuro-inflammation and promoting neurogenesis. The cells are harvested from healthy adult donors and manufactured at the Judith R. Hoffberger Cellular Therapeutics Laboratory at UTHealth Houston, an FDA-registered facility.
- Other names
- allogeneic mesenchymal stem cellsMSCs
Beyond the preview
Go deeper on allogeneic bone marrow-derived multipotent mesenchymal stromal cells.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on allogeneic bone marrow-derived multipotent mesenchymal stromal cells.